<DOC>
	<DOCNO>NCT02342743</DOCNO>
	<brief_summary>The purpose pilot study assess efficacy Cefaly device treatment chronic migraine prior implement control trial size final protocol specify thanks outcome pilot trial .</brief_summary>
	<brief_title>Open-trial Prevention Chronic Migraines With CEFALY Device</brief_title>
	<detailed_description />
	<mesh_term>Migraine Disorders</mesh_term>
	<criteria>Patients history chronic migraine meeting diagnostic criterion list ICHDIII beta ( 2013 ) section 1 , migraine ( 1 ) , exception `` complicate migraine '' ( i.e. , hemiplegic migraine , migraine brainstem aura , ophthalmoplegic migrainerecurrent painful ophthalmoplegic neuropathy , migrainous infarction ) enrol . They require baseline ≥15 headache day day consist ≥4 hour continuous headache ≥50 % day migraine probable migraine day ; ≥4 distinct headache episode , last ≥4 hour . Both patient without acute medication overuse ( medication overuse headache MOH ) recruit 1 . Women : Pregnant , lactate &lt; 6 month post partum 2 . For patient already treatment medication follow class : antihypertensive , antidepressant , antiepileptic , dose change medication allow least 3 month start baseline entire study period . 3 . For patient treated Botox , injection within 4 month start baseline study . 4 . Diagnosis primary secondary headache disorder , except Medication Overuse Headache 5 . A Beck Depression Inventory score &gt; 24 baseline 6 . Psychiatric disorder could interfere study participation 7 . Intolerance supraorbital neurostimulation make treatment applicable ( test nociceptive threshold specific Cefaly program )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>